The management of treatment-experienced HIV patients (including virologic failure and switches)

James Cutrell, Tomasz Jodlowski, Roger Bedimo

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Significant advances in the potency and tolerability of antiretroviral therapy (ART) have led to very high rates of virologic success for most who remain adherent to therapy. As a result, the life expectancy of people living with HIV (PLWH) has increased significantly. PLWH do, however, continue to experience a significantly higher risk of noninfectious comorbidities and chronic age-related complications, including cardiovascular disease and malignancies, which are now the biggest drivers of this excess morbidity and mortality. Therefore, in addition to virologic failure, the management of the treatment-experienced patient increasingly requires optimization of ART to enhance tolerability, avoid drug–drug interactions, and mitigate non-AIDS complications and comorbid conditions. This article will present principles of the management of virologic failure, poor immunologic recovery, and strategies for optimizing ART in the setting of virologic suppression.

Original languageEnglish (US)
JournalTherapeutic Advances in Infectious Disease
StatePublished - 2020


  • HIV
  • adherence
  • comorbidities
  • virologic failure

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)


Dive into the research topics of 'The management of treatment-experienced HIV patients (including virologic failure and switches)'. Together they form a unique fingerprint.

Cite this